NEW ISSUE
May 20
With the excitement of EuroPCR now in the past – and it was a wonderful moment to reconnect with colleagues and learn together – we move forward with thoughtful, original research on topics encompassing devices, techniques and, of course, the well- being of our patients.
ORIGINAL RESEARCH
May 20
Davide Cao, Roxana Mehran et al.
In high bleeding risk patients undergoing non-complex PCI with an everolimus-eluting stent, 1-month DAPT was associated with similar ischemic risk and reduced bleeding compared to 3-month DAPT, regardless of clinical presentation.
EDITORIAL
May 20
Myeong-Ki Hong, Yong-Joon Lee
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is required for 12 months in patients with acute coronary syndrome undergoing percutaneous coronary intervention to prevent ischemic events.
free
CONSENSUS
May 16
Francesco Burzotta, Goran Stankovic et al.
The 2023 European Bifurcation Club meeting discussed the use of IVUS and OCT to optimize PCI on coronary bifurcation lesions, but angiography is expected to remain the primary guidance modality. The EBC reviewed tips and tricks to optimize angiography-guided PCI for these lesions.
free
EDITORIAL
May 10
Patrick W. Serruys, Pruthvi C. Revaiah
The content discusses the importance of a multidisciplinary Heart Team approach in decision-making between CABG and PCI for complex coronary artery disease, and the potential use of QFR parameters in predicting clinical outcomes.
free
EDITORIAL
May 10
Roxana Mehran, Mauro Gitto
The article highlights the underrepresentation of women in cardiovascular clinical trials and the undertreatment of women with coronary artery disease in real-world practice, emphasizing the need for innovative strategies to include more women in trials and tailor management approaches.
free
May 14
Explore everything you need to know about Eurointervention at EuropCR 2024! From engaging sessions to simultaneous publications! And don't forget the EIJchallenge!
Join the EuroIntervention Challenge
May 10
Participate in the EuroIntervention Challenge—an exciting test of your interventional cardiology knowledge and enthusiasm! Plus, stand a chance to win a free ticket to EuroPCR 2025!
ORIGINAL RESEARCH
May 10
Taku Asano, Hitoshi Matsuo et al.
The FAVOR III Europe Japan trial aims to randomize 2000 patients to either a QFR-guided or FFR-guided strategy to evaluate whether QFR yields non-inferior 12-month clinical outcomes compared to FFR for intermediate coronary stenosis.
ORIGINAL RESEARCH
May 10
Mario Gaudino, Bjorn Redfors et al.
In the ISCHEMIA trial, women with stable coronary artery disease were less likely to undergo revascularization than men, but the effect of an invasive versus conservative management strategy was similar between sexes.
NEW ISSUE
May 10
Davide Capodanno
The special EuroPCR 2024 issue with the VARC-HBR consensus document; a debate on systematic OCT use in PCI; outcomes by sex from the ISCHEMIA trial; the DECISION QFR trial; CART in contemporary CTO PCI; SAPIEN 3 Ultra RESILIA; predictors of late lumen loss after DCBs for de novo lesions; new-onset atrial fibrillation after TAVI; and more!
ORIGINAL RESEARCH
May 8
Adil Salihu et al.
This study evaluated the ability of ChatGPT-4, a large language model, to assist in the decision-making process of Multidisciplinary Heart Teams for the management of severe aortic stenosis, finding a 77% agreement rate with the Heart Team's decisions.
RESEARCH CORRESPONDENCE
May 8
Gennaro Giustino, Pedro A. Villablanca et al.
This study reports the outcomes of 22 patients with refractory cardiogenic shock who underwent transcaval venoarterial extracorporeal membrane oxygenation, with a 54.6% in-hospital mortality rate and a high incidence of vascular and bleeding complications.
EDITORIAL
May 8
Valentin Koch
A study examines the use of ChatGPT in augmenting the decision-making processes of Heart Teams in the treatment of severe aortic stenosis, suggesting a high degree of alignment between the language model and the multidisciplinary teams.
free
Trending articles
Antiplatelet therapy after percutaneous coronary intervention
Transcatheter treatment for tricuspid valve disease
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study
Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy
Device-related thrombus following left atrial appendage occlusion
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR
Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry
State-of-the-Art Review
10.4244/EIJ-D-21-00904
•
Apr 1, 2022
Angiolillo D et al
free
State-of-the-Art Review
10.4244/EIJ-D-21-00695
•
Nov 19, 2021
Praz F et al
free
Expert consensus
10.4244/EIJ-D-21-00898
•
Sep 20, 2022
Secemsky E et al
free
Expert consensus
10.4244/EIJ-D-22-00958
•
May 12, 2023
Tarantini G et al
free
Clinical research
10.4244/EIJ-D-22-01062
•
Aug 21, 2023
Doldi PM et al
Clinical research
10.4244/EIJ-D-22-00886
•
May 12, 2023
van der Sangen NM et al
free
Clinical research
10.4244/EIJ-D-22-01125
•
Jul 17, 2023
Grubb KJ et al
Expert review
10.4244/EIJ-D-21-01010
•
Jun 24, 2022
Simard T et al
free
Clinical research
10.4244/EIJ-D-23-00282
•
Jul 17, 2023
Kodali SK et al
Clinical research
10.4244/EIJ-D-19-00428
•
Feb 7, 2020
Chieffo A et al
free
